Together with JEMPERLI logo

Together with JEMPERLI is more than a program—it’s our promise to understand your needs, listen to what matters most to you, and create meaningful connections along the way.

 

Once your doctor has prescribed JEMPERLI, we will help you to understand the medication coverage process, investigate affordable options, and guide you through your care.

Here’s what you can expect from Together with JEMPERLI:

Coverage Support

We’ll check your insurance coverage and help you understand your benefits.* Together with JEMPERLI is here to help you navigate coverage and provide ongoing support.

*The information provided by Together with JEMPERLI is not a guarantee of coverage or payment.

Cost Support

We’re here to let you know about the options for help paying for JEMPERLI if you are eligible.

Patient Support

Your Patient Navigatoris at the heart of our program, offering tailored support throughout your treatment journey.

The Patient Navigator does not provide medical advice and is not a part of your doctor’s care team. Please ask your doctor any questions that you might have about your disease and treatment with JEMPERLI.

Discover More

Explore additional benefits of Together with JEMPERLI and enroll.

Once you are enrolled, your support will be tailored to you

You Have Cost Support Options

Paying for medicine is not one-size-fits-all. The necessary support can be vastly different depending on your needs and insurance coverage. Together with JEMPERLI offers assistance with finding affordable options like copay or patient assistance programs for eligible patients.

 

Learn More

JEMPERLI Copay Program

Eligible, commercially insured patients may pay as little as $0‡ for JEMPERLI.

 

The JEMPERLI Copay Program helps eligible commercially insured patients with their eligible out-of-pocket costs for JEMPERLI.

Program annual maximums apply.

Visit TogetherwithJEMPERLI.com for information about eligibility and full program terms and conditions.

Your Patient Navigator can answer questions about insurance benefits and out-of-pocket costs. They can help you understand financial assistance and provide you with information about the product.

§The Patient Navigator does not provide medical advice and is not a part of your doctor’s care team. Please ask your doctor any questions that you might have about your disease and treatment with JEMPERLI.

Downloadable resources

JEMPERLI Patient Brochure

Learn more about JEMPERLI in this informative brochure, ready to download or print.

Download PDF

Knowledge Is Gold Brochure

An in-depth look into terms and concepts behind endometrial cancer and a JEMPERLI clinical trial.

Download PDF

Celebrate the JEMs Brochure

A care partner's guide to supporting your loved one through milestones, or JEMs, they may experience throughout their treatment journey.

Download PDF

Discussion Guide

Learn how to start conversations about endometrial cancer and your JEMPERLI treatment with your care team, loved ones, and community.

Download PDF

Wellness Guide

Here you’ll find information about endometrial cancer, learn what you may expect during treatment, and get tips for talking to your care team about general wellness.

Download PDF

Side Effects Guide

Learn more about potential side effects associated with JEMPERLI treatment.

Download PDF

Care Partner Guide

Created especially for care partners, this guide explains how to support a loved one throughout their endometrial cancer journey. It also includes tips on taking care of themselves.

Download PDF

Glossary

To provide you with a better understanding of the terms, acronyms, and phrases that may be frequently used by your care team.

Download PDF

Frequently asked questions

    Approved Uses & Safety Info

    Approved Uses

    Important Safety Information

    Approved Uses

    JEMPERLI is a prescription medicine used to treat adults with:

    • a kind of uterine cancer called endometrial cancer (EC)
      • JEMPERLI may be used in combination with the chemotherapy medicines, carboplatin and paclitaxel, and then after that JEMPERLI may be used alone:
      • when your cancer has spread outside your uterus (advanced) or,
      • your cancer has returned.
    • JEMPERLI may be used alone:
      • when a laboratory test shows that your tumor is mismatch repair deficient (dMMR), and
      • your cancer has returned, or it has spread (advanced EC), and
      • you have received chemotherapy that contains platinum and it did not work or is no longer working, and
      • your cancer cannot be treated by surgery or radiation.
    • a kind of cancer that is shown by laboratory test to be dMMR solid tumor. JEMPERLI may be used alone to treat:
      • cancer that has returned or has spread (advanced cancer) and,
      • has progressed during treatment or after treatment, and you have no satisfactory treatment options.
      • This use is approved based on how many patients responded to treatment and how long they responded. Studies are ongoing to confirm the clinical benefit of JEMPERLI for this use.

     

    It is not known if JEMPERLI is safe and effective in children.

    Important Safety Information

    JEMPERLI is a medicine that may treat certain cancers by working with your immune system. JEMPERLI can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.

     

    Call or see your healthcare provider (HCP) right away if you develop any new or worsening signs or symptoms, including:

     

    Lung problems. Signs and symptoms may include cough, shortness of breath, or chest pain.

     

    Intestinal problems. Signs and symptoms may include diarrhea or more bowel movements than usual; stools that are black, tarry, sticky, or have blood or mucus; or severe stomach-area (abdomen) pain or tenderness.

     

    Liver problems. Signs and symptoms may include yellowing of your skin or the whites of your eyes, severe nausea or vomiting, pain on the right side of your stomach area (abdomen), dark urine (tea colored), or bleeding or bruising more easily than usual.

     

    Hormone gland problems. Signs and symptoms may include headaches that will not go away or unusual headaches, eye sensitivity to light, eye problems, rapid heartbeat, increased sweating, extreme tiredness, weight gain or weight loss, feeling more hungry or thirsty than usual, urinating more often than usual, hair loss, feeling cold, constipation, your voice gets deeper, dizziness or fainting, changes in mood or behavior such as decreased sex drive, irritability, or forgetfulness.

     

    Kidney problems. Signs and symptoms may include change in the amount or color of your urine, blood in your urine, swelling in your ankles, or loss of appetite.

     

    Skin problems. Signs and symptoms may include rash; itching; skin blistering or peeling; swollen lymph nodes; painful sores or ulcers in your mouth or in your nose, throat, or genital area; fever or flu-like symptoms.

     

    Problems can also happen in other organs and tissues. These are not all of the signs and symptoms of immune system problems that can happen with JEMPERLI. Call or see your HCP right away for any new or worse signs or symptoms. Signs and symptoms may include chest pain, irregular heartbeat, shortness of breath, swelling of ankles; confusion, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness of the arms or legs; double vision, blurry vision, sensitivity to light, eye pain, changes in eyesight; persistent or severe muscle pain or weakness, muscle cramps; low red blood cells, bruising.

     

    Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include chills or shaking, itching or rash, flushing, shortness of breath or wheezing, dizziness, feel like passing out, fever, back or neck pain.

     

    Rejection of a transplanted organ. Your HCP should tell you what signs and symptoms you should report and monitor you, depending on the type of organ transplant that you have had.

     

    Complications, including graft-versus-host-disease (GVHD), in people who have received a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic). These complications can be serious and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with JEMPERLI. Your HCP will monitor you for these complications.

     

    Getting medical treatment right away may help keep these problems from becoming more serious. Your HCP will check you for these problems during treatment with JEMPERLI and may treat you with corticosteroid or hormone replacement medicines. If you have severe side effects, your HCP may also need to delay or completely stop treatment with JEMPERLI.

     

    Before receiving JEMPERLI, tell your HCP about all of your medical conditions, including immune system problems such as Crohn's disease, ulcerative colitis, or lupus; received an organ transplant; have received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic); have received radiation treatment to your chest area; have a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barré syndrome.

     

    If you are pregnant or plan to become pregnant, tell your HCP. JEMPERLI can harm your unborn baby. If you are able to become pregnant, your HCP will give you a pregnancy test before you start treatment. Use an effective birth control method during treatment and for 4 months after your last dose of JEMPERLI. Tell your HCP right away if you become pregnant or think you may be pregnant during treatment with JEMPERLI.

     

    If you are breastfeeding or plan to breastfeed, tell your HCP. It is not known if JEMPERLI passes into your breast milk. Do not breastfeed during treatment with JEMPERLI and for 4 months after your last dose.

     

    Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

     

    The most common side effects of JEMPERLI when given with carboplatin and paclitaxel include nerve problems in your arms, hands, legs, and feet; tiredness; nausea; hair loss; joint pain; rash; constipation; diarrhea; stomach-area (abdomen) pain; shortness of breath; decreased appetite; urinary tract infections; vomiting.

     

    The most common side effects of JEMPERLI when used alone include tiredness and weakness, low red blood cell count (anemia), diarrhea, nausea, constipation, vomiting.

     

    These are not all of the possible side effects of JEMPERLI. Call your doctor for medical advice about side effects.

     

    Please see full Prescribing Information, including Medication Guide for patients.

    You are encouraged to report negative side effects of prescription drugs to the FDA.
    Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report negative side effects to GSK at gsk.public.reportum.com or 1-888-825-5249.
    GSK Help Center logo

    Explore the GSK Help Center website to find customer service support and contact information.

    Together with JEMPERLI logo

    If you have questions about how to access or pay for JEMPERLI, visit TogetherwithJEMPERLI.com or call 1-844-4GSK-ONC (1-844-447-5662).